businessneutral

Stocks on the Move: A Midday Market Roundup

Texas, USAWednesday, December 17, 2025

The stock market was buzzing with activity at midday, with several companies seeing significant shifts in their share prices.

Texas Pacific Land

  • Shares up 8%
  • Partnership: Teamed up with Bolt Data & Energy to build large-scale data centers on its properties.

Jabil

  • Initial rise: 5% after releasing an optimistic forecast.
  • Later dip: 2%.
  • Year-to-date: 45% increase due to growing demand for AI data centers.

Oracle

  • Shares down 6%
  • Reason: Blue Owl would not support Oracle's plans for a $10 billion data center in Michigan.

Coursera & Udemy

  • Deal: Coursera acquires Udemy, valuing the combined company at $2.5 billion.
  • Stock movements:
  • Coursera: +3%
  • Udemy: +21%

8Hut

  • Shares up 11%
  • Partnership: With Anthropic and Fluidstack to develop AI infrastructure.

Brown-Forman

  • Shares down nearly 5%
  • Reason: Downgrade from Citigroup citing overperformance and category challenges.

Dbv Technologies

  • U.S.-listed shares up over 20%
  • Reason: Positive results from a Phase 3 trial for peanut allergy treatment in children.

Warner Bros. Discovery & Netflix

  • Board recommendation: Reject Paramount Skydance's takeover bid, stick with Netflix's "superior" proposal.
  • Stock movements:
  • Netflix: +2%
  • Warner Bros. Discovery: -1%
  • Paramount: -5%

Lennar

  • Shares down 5%
  • Reason: First-quarter guidance disappointed investors, with homebuilding gross margin of 15% to 16%.

Frontier Group & Spirit Aviation

  • Frontier Group: +3%
  • Spirit Aviation: +15%
  • Reason: Discussions about a potential merger.

General Mills

  • Shares up 3%
  • Reason: Earnings results exceeded expectations, reporting adjusted earnings of $1.10 per share on revenue of $4.86 billion.

Lithium Stocks

  • Surge in prices
  • Reason: Chinese government plans to revoke mining licenses.
  • Key movers:
  • Albemarle: +5%
  • Sociedad Quimica y Minera de Chile: +5%
  • Lithium Argentina: +4%

Recursion Pharmaceuticals

  • Shares up almost 16%
  • Reason: Upgrade at JPMorgan, citing its AI pipeline and upping the price target to $11 per share.

Actions